Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center to deploy its nPulse Vybrance Percutaneous Electrode System and collect clinical data.
The Clayman Thyroid Center is treating patients with Pulse Biosciences’ Vybrance percutaneous electrode system and will collaborate on real-world outcomes and formal studies in benign thyroid nodules.
For best results when printing this announcement, please click on link below: Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center Collaboration adds the nPulse™ Vybrance™ System to patient care at the Hospital for Endocrine Surgery and supports generation of additional clinic